Gladstone Institutional Advisory LLC

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1766530 Bedminster, NJ

Position in SRPT

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$302,137

-$57,569 QoQ

Shares Held

13,885

-16.9% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Gladstone Institutional Advisory LLC holds $2,203,514 across 10 Biotechnology names. SRPT ranks #4 (13.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	6,091	$573,284
2	IBRX	ImmunityBio, Inc.	51,418	$394,376
3	VKTX	Viking Therapeutics, Inc.	9,552	$310,822
4	SRPT	Sarepta Therapeutics, Inc. This page	13,885	$302,137
5	REGN	Regeneron Pharmaceuticals, Inc.	383	$295,921
6	AVXL	Anavex Life Sciences Corp.	72,381	$222,209
7	GALT	Galectin Therapeutics Inc	23,900	$66,681
8	CRDF	Cardiff Oncology, Inc.	13,000	$21,060

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$302,137	13,885	-16.9%	Shares	Sole	2026-05-14
2025-12-31	$359,706	16,715	-24.8%	Shares	Sole	2026-02-17
2025-09-30	$428,468	22,235	-20.2%	Shares	Sole	2025-10-22
2025-06-30	$476,508	27,866	-59.6%	Shares	Sole	2025-08-12
2025-03-31	$4,401,027	68,960	-6.7%	Shares	Sole	2025-05-15
2024-12-31	$8,983,677	73,885	-11.3%	Shares	Sole	2025-01-29
2024-09-30	$10,403,337	83,300	+47.7%	Shares	Sole	2024-10-28
2024-06-30	$8,911,200	56,400	+0.1%	Shares	Sole	2024-08-02
2024-03-31	$7,296,365	56,360	+2195.7%	Shares	Sole	2024-05-14
2021-09-30	$227,038	2,455	—	Shares	Sole	2023-01-30
No filing history on record for this holder in this stock.